Close
Login to MyACC
ACC Members


Not a Member?

The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.

Join ACC

Search Filters
Global Legal Group
326 pages

This multi-jurisdictional guide covers common issues in pharmaceutical advertising laws and regulations.

Topics covered include advertisements to healthcare professionals, gifts and financial incentives, hospitality and related payments, and transparency and disclosure.

Resource Details
Interest Area: Health Law
Region: Global, Argentina, Australia, Austria, Belgium, Finland, Germany, Greece, Ireland, Italy, Japan, Mexico, Poland, Portugal, Romania, Singapore, Slovakia, South Korea, Spain, Sweden, Switzerland, Thailand, United Kingdom, United States, European Union
Lauren Rucinski, Josiah Kollmeyer, Daniel Bosch, and Andre Bellefontaine (Kean Miller LLP)

The U.S. Supreme Court’s decision overturning Chevron deference. This articles discusses the ruling, which calls for courts to reassume their role as interpreters of the law.

Lori Garber, Partner (Foley & Lardner LLP)

This article provides an overview of the False Claims Act (FCA).

In this article you will learn about, the types of FCA cases in health care, damages and penalties under the FCA, and cooperation considerations for companies and individuals under government scrutiny.

ACC Houston CLE Webinar 
Navigating the FTC's Non-Compete Ban: Implications and Strategies for Businesses and Organizations 
July 16, 2024 | 11 am - 12 pm CDT | 1.00 HOURS CLE (TX) 

In a landmark decision, the Federal Trade Commission (FTC) announced a final rule in April – effective September 4 – that prohibits most non-compete agreements between employers and workers. This groundbreaking development has significant implications for businesses and employees, impacting competitive conditions in labor markets, mergers and acquisitions, employee benefits, and beyond.

This program will cover key considerations when using telemedicine in clinical trials so in-house counsel can issue spot and advise their clients on this important and burgeoning clinical trial modality.

image

This program will cover key considerations when using telemedicine in clinical trials so in-house counsel can issue spot and advise their clients on this important and burgeoning clinical trial modality.

image

This program originally aired on March 21, 2024. Please note that this program recording is not eligible for CLE/CPD credit.

image


Presented by:

Jennee DeVore
VP, Legal
Inflammatix

Julia Kaufmann
Partner, Germany
Osborne Clarke

Laurene Zaggia
Counsel, France
Osborne Clarke

image


Foley & Lardner LLP
28 pages

Foley & Lardner’s Top Trends for 2024 publication unpacks key developments in an uncertain regulatory landscape.

Roger D. Strode, Mark C. Grundvig, Kate L. Pamperin, Joseph T. Simon, and Benjamin R. Dryden (Foley & Lardner LLP)
8 pages

On April 23, 2024, the U.S. Federal Trade Commission finalized a rule, by a vote of 3-2, abolishing the vast majority of employee covenants not to compete across the United States.

While certain health care providers will be exempted from the rule, many will not. As such, and if the rule survives legal challenge, health care industry participants should carefully consider how the rule will impact their recruitment and retention strategies going forward.

Resource Details
Region: United States

As the provision of health care services continues to evolve with technological advances, hospitals, health systems, physician groups and health care providers, are examining new ways and methods to provide health care to their populations, including teaming with new and complementary business partners. The world of health care is changing quickly, and joint venture arrangements are becoming a new normal, even with all the regulatory, transactional, and shared management complexities that come with them. This Webcast will discuss the following: 

• Defining a health care joint venture; 

• Health care regulatory concerns; 

• Brand and reputation management; 

• Management structures; and 

• Transactional considerations (e.g., antitrust, exclusivity, ROFR, drag and tag along rights).

image


Subscribe to Health Law
ACC